Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.020
+0.020 (0.67%)
Apr 2, 2026, 4:00 PM EDT - Market closed
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,517,833
Market Cap
28.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 34 |
| Senti Biosciences | 34 |
| Actinium Pharmaceuticals | 25 |
| ABVC BioPharma | 19 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Hyperion DeFi | 14 |
| Serina Therapeutics | 13 |
TVRD News
- 3 days ago - Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium - GlobeNewsWire
- 4 days ago - Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - GlobeNewsWire
- 3 months ago - INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - PRNewsWire
- 3 months ago - SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - GlobeNewsWire
- 4 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - PRNewsWire
- 4 months ago - Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Business Wire